Effects of chromium supplementation on lipid profile: An umbrella of systematic review and meta-analysis

M Vajdi, V Musazadeh, A Karimi, H Heidari… - … Trace Element Research, 2023 - Springer
Dyslipidemia is one of the most well-established modifiable risk factors for cardiovascular
disease (CVD) development. Several meta-analyses have revealed the improving effects of …

The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital

AK Dixit, R Dey, A Suresh, S Chaudhuri… - Journal of Diabetes & …, 2014 - Springer
Background Dyslipidemia is one of the major risk factors for cardiovascular disease in
diabetes mellitus. Early detection and treatment of dyslipidemia in type-2 diabetes mellitus …

[HTML][HTML] Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population

M Sarfraz, S Sajid, MA Ashraf - Saudi journal of biological sciences, 2016 - Elsevier
In diabetes mellitus dyslipidemia is one of the major risk factors for cardiovascular disease.
In type 2 diabetes mellitus early detection and treatment of dyslipidemia can avoid risk for …

Prevalence of dyslipidemia and associated risk factors among newly diagnosed Type-2 Diabetes Mellitus (T2DM) patients in Kushtia, Bangladesh

MS Ahmmed, SD Shuvo, DK Paul… - PLOS global public …, 2021 - journals.plos.org
Dyslipidemia is considered a significant modifiable risk factor for type-2 diabetes mellitus
(T2DM) and has become one of the emerging health problems throughout the world. In …

Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People's Region

S Bekele, T Yohannes… - … , metabolic syndrome and …, 2017 - Taylor & Francis
Background Diabetes mellitus is a group of metabolic disorders that are caused by
deficiency in insulin secretion or the decreased ability of insulin to act effectively on target …

[HTML][HTML] A review of recent evidence from meal-based diet interventions and clinical biomarkers for improvement of glucose regulation

Y Jeong, E Lee, YJ Park, Y Kim, O Kwon… - Preventive nutrition and …, 2020 - ncbi.nlm.nih.gov
In recent decades, the prevalence of diabetes has rapidly increased worldwide. Medical
nutrition therapy has been identified as a major therapeutic support for diabetic patients …

In Vivo and In Vitro Antidiabetic Activity of Terminalia paniculata Bark: An Evaluation of Possible Phytoconstituents and Mechanisms for Blood Glucose Control in …

S Ramachandran, A Rajasekaran… - International Scholarly …, 2013 - Wiley Online Library
The present study was aimed to investigate in vivo, in vitro antidiabetic activity of aqueous
extract of Terminalia paniculata bark (AETPB) and characterize its possible …

A comparative prevalence of metabolic syndrome among type 2 diabetes mellitus patients in Hawassa University Comprehensive Specialized Hospital using four …

T Bizuayehu Wube, M Mohammed Nuru… - … syndrome and obesity …, 2019 - Taylor & Francis
Background Recognition of MetS in type two diabetic patients is important in starting the
appropriate preventive and therapeutic measures. The commonly used definitions of MetS …

Non-alcoholic fatty liver disease and associated factors among type 2 diabetic patients in Southwest Ethiopia

B Zawdie, S Tadesse, AD Wolide, TA Nigatu… - Ethiopian Journal of …, 2018 - ajol.info
Background: Non-alcoholic Fatty Liver Disease (NAFLD) among type 2 diabetic patients is
completely ignored in developing regions like Africa paving the way for public health and …

Candesartan protects against unilateral peripheral limb ischemia in type-2 diabetic rats: possible contribution of PI3K-Akt-eNOS-VEGF angiogenic signaling pathway

S Khaled, RR Abdelaziz, GM Suddek… - International …, 2023 - Elsevier
Abstract Type-2 diabetes (T2DM) is known to be highly associated with increased risk for
vascular complications including peripheral arterial diseases (PAD). Critical limb ischemia …